Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017;377(12):1177–87.
CampelloSpieziaAdamoi Simioni ELAP. Thrombophilia, Risk Factors and Prevention. Expert Rev Hematol. 2019;12(3):147–58.
Cushman M, Tsai AW, White RH, Heckbert SR, Wayne D, Enright RP, Folsom AR. Deep Vein Thrombosis and Pulmonary Embolism in Two Cohorts: The Longitudinal Investigation of Thromboembolism Etiology. The American Journal of Medicine. 2004;117(1):19–25.
Article
Google Scholar
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, BergqvistBrecht DJG, Greer IA, et al. Venous Thromboembolism (VTE) in Europe. The Number of VTE Events and Associated Morbidity and Mortality. Thromb Haemost . 2007;98(4):756–64.
CAS
PubMed
Google Scholar
Niżankowski R. Comment to: “Wytyczne profilaktyki i leczenia żylnej choroby zakrzepowo-zatorowej.” Med Prakt. 2002;5:100–1.
Lim W. Prevention of thrombosis in antiphospholipid syndrome. Hematology. 2016;2016(1):707–13.
Article
Google Scholar
Anderson FA, Spencer FA. Risk Factors for Venous Thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-16.
PubMed
Google Scholar
Ming LY, Moll S. Thrombophilia. Vasc Med . 2015;20(2):193–6.
Article
Google Scholar
Zangari M, Elice F, Tricot G, Fink L. Thrombophilia. Drug Target Insights. 2008;3:DTI.S568. https://doi.org/10.4137/DTI.S568.
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in Blood Coagulation Factor V Associated with Resistance to Activated Protein C. Nature. 1994;369(6475):64–7.
Article
CAS
Google Scholar
Kujovich JL, Factor V. Leiden Thrombophilia. Genet Med . 2011;13(1):1–16.
Article
CAS
Google Scholar
Koster T, Rosendaal FR, de Ronde H, Briët HE, Vandenbroucke JP, Bertina RM. Venous Thrombosis Due to Poor Anticoagulant Response to Activated Protein C: Leiden Thrombophilia Study. Lancet . 1993;342(8886 8887):1503–6.
Article
CAS
Google Scholar
GohilPeck RG, Sharma P. The Genetics of Venous Thromboembolism. A Meta-Analysis Involving Approximately 120,000 Cases and 180,000 Controls. Thromb Haemost. 2009;102(2):360–70.
Lijfering WM, Brouwer JLP, Veeger NJGM, Bank I, Coppens M, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Mee Jr. Selective Testing for Thrombophilia in Patients with First Venous Thrombosis: Results from a Retrospective Family Cohort Study on Absolute Thrombotic Risk for Currently Known Thrombophilic Defects in 2479 Relatives. Blood. 2009;113(21):5314–22.
Article
CAS
Google Scholar
Delluc A, Le Moigne E, Tromeur C, Noel-Savina E, Couturaud F, Mottier D, Le Gal G, Lacut K. Site of Venous Thromboembolism and Prothrombotic Mutations According to Body Mass Index. Results from the EDITH Study. Br J Haematol . 2011;154(4):486–91.
Article
Google Scholar
Adler G, Clark JSC, Loniewska B, Czerska E, Salkic NN, Ciechanowicz A. Prevalence of 1691G>A FV Mutation in Poland Compared with That in Other Central, Eastern and South-Eastern European Countries. Bosnian J Basic Med Sci . 2012;12(2):82–7.
CAS
Google Scholar
Clark JSC, Adler G, Salkic NN, Ciechanowicz A. Allele frequency distribution of 1691G>A F5 (which confers Factor V Leiden) across Europe, including Slavic populations. J Appl Genet. 2013;54(4):441–6.
Article
Google Scholar
van KjellbergRooijenBremmeHellgren UMKM. Factor V Leiden variant and pregnancy-related complications. Am J ObstetGynecol. 2010;203:469e1–8.
Article
Google Scholar
Berge E, HaugKBF SEC, Haugbro KK, TurkovicM SPM. The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation. Stroke. 2007;38:1069–71.
Article
CAS
Google Scholar
Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 1999;93:906–8.
Article
CAS
Google Scholar
Fischer A, Procopciuc L, Jebeleanu G. Analysis of Factor V Leiden in women with fetal loss using single strand conformation polymorphism. TMJ. 2006;56:18–22.
Google Scholar
Valjevac A, Mehic B, Kiseljakovic E, Ibrulj S, Garstka A, Adler G. Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina - a preliminary report. Bosn J Basic Med Sci. 2013;13(1):31–3.
Article
CAS
Google Scholar
Hiltunen L, Rautanen A, Rasi V, Kaaja R, Kere J, Krusius T, Vahtera E, Paunio M. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancyassociated venous thrombosis: a population-based nested case–control study. Thromb Res. 2007;119:423–32.
Article
CAS
Google Scholar
Adler G, Garstka A, Valjevac A, Czerska E, Kiseljakovic E, Salkic NN. Prevalence of Genetic Prothrombotic Risk Factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR Mutations in the Bosnian Population. Ann Hum Biol. 2015;42(6):576–80.
Article
Google Scholar
Settin AA, Alghasham A, Ali A, Dowaidar M, Ismail H. Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations. Hematology. 2012;17(3):176–82.
Article
CAS
Google Scholar
Martinelli I, Taioli E, Cetin I, Marinoni A, Marinoni A, Gerosa S, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343(14):1015–9.
Article
CAS
Google Scholar
Walker P, Gregg AR. Screening, Testing, or Personalized Medicine: Where Do Inherited Thrombophilias Fit Best? Obstet Gynecol Clin North Am. 2010;37(1):87–107.
Article
Google Scholar
Shulin Z, Taylor AK, Huang X, Luo B, Spector EB, Fang P, Richards CS. Venous Thromboembolism Laboratory Testing (Factor V Leiden and Factor II c.*97G>A), 2018 Update: A Technical Standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20(12):1489–98.
Article
Google Scholar